Why the study?
Do NOS 3 gene polymorphisms or plasma NOx levels predict the risk of ischemic heart disease in middle-aged men?
Population
3052 middle-aged men initially free of ischemic heart disease, recruited from 9 UK primary care practices.
Design
Cohort
Follow-up
8.1 years
Authors
Loading...
Lower NOx in smokers was independent of NOS3 genotype and IHD risk; leaves open whether NOx or these variants predict events in middle-aged men.
Do NOS 3 gene polymorphisms or plasma NOx levels predict the risk of ischemic heart disease in middle-aged men?
While smoking is associated with reduced NO bioactivity, NOS 3 genotype does not appear to influence plasma NOx levels or IHD risk in middle-aged British men.
Jeerooburkhan et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: